The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers

Inge-Marie Obdeijn*, Ritse M. Mann, Claudette C. E. Loo, Marc Lobbes, Eleonora M. C. Voormolen, Carolien H. M. van Deurzen, Geertruida de Bock, Maartje J. Hooning, Hereditary Breast Ovarian Cancer Research Group Netherlands (HEBON)

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)581-588
Number of pages8
JournalBreast Cancer Research and Treatment
Volume181
Issue number3
DOIs
Publication statusPublished - Jun 2020

Keywords

  • BRCA mutation carriers
  • Screening
  • MRI
  • Mammography
  • CHROMOSOMAL RADIOSENSITIVITY
  • CANCER
  • WOMEN
  • RISK
  • SURVEILLANCE
  • ULTRASOUND

Cite this